Dr Milan Dragovic
The Academic Details listed below present information collected by the University up to the end of 2013 and thus may not represent the full academic record.
Phone: 9347 6442
Laugharne, J., Waterreus, A.J., Castle, D.J., Dragovic, M. 2016, 'Screening for the metabolic syndrome in Australia: a national survey of psychiatrists' attitudes and reported practice in patients prescribed antipsychotic drugs', AUSTRALASIAN PSYCHIATRY, 24, 1, pp. 62-66. Detail
Bruce, D.G., Davis, W.A., Dragovic, M., Davis, T.M.E., Starkstein, S.E. 2016, 'Comorbid Anxiety and Depression and Their Impact on Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study Phase II', Depression and Anxiety, 33, 10, pp. 960-966. Detail
John, A.P., Dragovic, M. 2015, 'Antipsychotic polypharmacy is not associated with reduced dose of individual antipsychotics in schizophrenia', Journal of Clinical Psychopharmacology, 35, 2, pp. 193-195. Detail
Starkstein, S.E., Dragovic, M., Brockman, S., Wilson, M., Bruno, V., Merello, M.L. 2015, 'The impact of emotional distress on motor blocks and festination in parkinson’s disease', Journal of Neuropsychiatry and Clinical Neurosciences, 27, 2, pp. 121-126. Detail
Power, B.D., Dragovic, M., Badcock, J.C., Morgan, V.A., Castle, D., Jablensky, A., Stefanis, N.C. 2015, 'No additive effect of cannabis on cognition in schizophrenia', Schizophrenia Research, 168, 1-2, pp. 245-251. Detail
Dr Johanna Badcock, Professor Assen Jablensky, Dr Milan Dragovic 2002, 'High functioning people with schizophrenia: Neurocognitive and clinical profile', WA Foundation for Research into Schizophrenic Disorders.
2010 PhD. Dr Mazhari. Supervised by: Prof Jablensky, Dr Waters, Dr Price, Dr Dragovic